Accolade Inc
NASDAQ:ACCD

Watchlist Manager
Accolade Inc Logo
Accolade Inc
NASDAQ:ACCD
Watchlist
Price: 7.02 USD Market Closed
Market Cap: 575.6m USD

Accolade Inc
Investor Relations

Accolade, Inc. engages in the provision of personalized health and benefits solutions. The company is headquartered in Seattle, Washington and currently employs 2,350 full-time employees. The company went IPO on 2020-07-02. The Company’s customers are primarily employers that deploy Accolade in order to provide employees and their families members a single place to turn for their health, healthcare, and benefits needs. Its platform combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. The firm leverages its integrated capabilities, connectivity with providers and the healthcare ecosystem, and longitudinal data to engage across the member population. Its offerings are: Accolade Total Benefits, Accolade Total Care, Accolade Total Health and Benefits, Accolade Boost, the Trusted Supplier Program, and Mental Health Integrated Care solutions.

Show more
Loading

Earnings Calls

2024 Q3
Oct 24, 2024
Show Transcript
Previous
Next
Bankinter shows strong growth with improved margins and focused risk management.
2024 Q3
Oct 24, 2024

Bankinter reported solid third-quarter results, with a 5% growth in loans and retail deposits, while off-balance sheet products surged by 23%. The bank achieved a 7% increase in total operating income to €2,151 million, driven by a 5.5% rise in net interest income and a remarkable 14% boost in fees. Profit before taxes rose 8% year-on-year to €1,083 million. Furthermore, the bank maintained a comfortable NPL ratio of 2.2% and a strong CET1 ratio of 12.56%. Looking ahead, expectations for 2025 include continued revenue growth despite potential interest rate declines, with a net interest income target of mid-single digits.

Show Full Analysis

Management

Mr. Rajeev Singh
Chairman of the Board & CEO
No Bio Available
Mr. Robert Cavanaugh
President
No Bio Available
Mr. Stephen H. Barnes CPA
CFO & Treasurer
No Bio Available
Mr. Richard Eskew J.D.
Executive VP, General Counsel, CCO & Secretary
No Bio Available
Ms. Kristen Bruzek
Senior Vice President of Operations
No Bio Available
Mr. Colin McHugh
Chief Accounting Officer
No Bio Available
Mr. Todd Friedman
Senior Vice President of Investor Relations
No Bio Available
Ms. Kelsi McDonald Harris
Chief People Officer & Senior Vice President
No Bio Available
Mr. Drew Garner
Executive Vice President of Engineering
No Bio Available
Dr. Shantanu Nundy M.B.A., M.D.
Executive VP, Chief Health Officer & Member of the Medical Advisory Board
No Bio Available

Contacts

Address
WASHINGTON
Seattle
1201 Third Avenue, Suite 1700
Contacts
+12069268100.0
www.accolade.com